Tackling Difficult Staphylococcus aureus Infections: Antibodies Show the Way

Publication date: 9 November 2016
Source:Cell Host & Microbe, Volume 20, Issue 5
Author(s): Bo Shopsin, Srini V. Kaveri, Jagadeesh Bayry
The recent spread of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) has brought increasing concerns of heightened disease severity and persistence following invasive disease. In line with the need for new treatment paradigms, two recent reports have shown that antibody-based therapies can restrict acute S. aureus infection and persistence and improve pathological symptoms.

Teaser

The recent spread of community-acquired methicillin-resistant Staphylococcus aureus has brought increasing concerns of heightened disease severity and persistence following invasive disease. In line with the need for new treatment paradigms, two recent reports have shown that antibody-based therapies can restrict acute S. aureus infection and persistence and improve pathological symptoms.


http://rss.sciencedirect.com/action/redirectFile?&zone=main&currentActivity=feed&usageType=outward&url=http%3A%2F%2Fwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_origin%3DIRSSSEARCH%26_method%3DcitationSearch%26_piikey%3DS1931312816304449%26_version%3D1%26md5%3D77797906578ad26922d68ab52150ab33